Alexion Pharmaceuticals (ALXN) PT Lowered to $150 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Hartaj Singh lowered the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $150.00 (from $165.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
